Avicanna Inc

Research Avicanna Inc (AVCN) on Bullrun: market cap CAD 15.41M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAVCN
• ExchangeTO
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyCAD
• Market capCAD 15.41M
• Financial periodQ4 2025
• RevenueCAD 6.60M
• Net income-CAD 834.86K
• Free cash flow-CAD 198.93K
• Gross margin55.1%

Valuation Snapshot

latest market cap is CAD 15.41M.

About Avicanna Inc

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand;

Frequently asked questions

What is Avicanna Inc's market cap?

Avicanna Inc's market capitalization is CAD 15.41M.

What does Avicanna Inc do?

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally.